Please login to the form below
CFDA
This page shows the latest CFDA news and features for those working in and with pharma, biotech and healthcare.
AZ pushes harder into China with new joint venture
CFDA) in March. ... AppTec. The decision to invest in the country has dovetailed with recent efforts by the CFDA to do away with bureaucratic red-tape and bring the country’s regulatory systems into
Latest news
-
AZ gets rapid approval in China for Tagrisso
Tagrisso (osimertinib) - a third-generation EGFR inhibitor - has been approved by the China Food and Drug Administration (CFDA) as a second-line treatment for EGFR T790M mutation-positive metastatic non-small ... They are also a recognition by the CFDA
-
AZ and Ironwood to file IBS drug linaclotide in China next year
If approved by the China Food and Drug Administration (CFDA) linaclotide would be the first prescription drug specifically approved for IBS-C in the country, said Leon Wang, president of
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
China: AstraZeneca’s new engine for growth and innovation
In March 2017, AZ’s targeted lung cancer drug Tagrisso was one of the first medicines to gain approval through the Chinese Food and Drug Administration (CFDA)’s Priority Review pathway,
-
Chinese biotech’s global ambitions
PD-1 contender filed in China. The company has just announced that it has filed tislelizumab with China’s National Medical Products Administration of China (NMPA, formerly known as CFDA or
-
A catalyst for change
After a review, the CFDA may choose to fully accept, partially accept or refuse the submitted overseas data. ... If there is no judgment delivered, the CFDA may proceed to approve the registration.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
- HCP ENGAGEMENT STUDY: Pharma shifts top priority to HCP insights and impact metrics
- AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer
- BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer
- Stanford Medicine researchers find blood tests help predict organ failure
- GSK and GCOA report reveals global inequities in adult immunisation uptake
- A “Leaky Pipeline” and the Loss of Talented Female Physicians
No results were found
PMHub
Cuttsy + Cuttsy
Here at Cuttsy+Cuttsy, we believe in making the world a better place by bringing trusted, accessible information to all and...
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
